Trial Profile
Multicenter randomized phase II trial of S-1/ L-OHP (SOX) as an adjuvant treatment after resection of liver metastasis from colorectal carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 17 May 2016 New trial record